Literature DB >> 11994371

Follicle-stimulating hormone activates mitogen-activated protein kinase in preneoplastic and neoplastic ovarian surface epithelial cells.

Kyung-Chul Choi1, Sung Keun Kang, Chen-Jei Tai, Nelly Auersperg, Peter C K Leung.   

Abstract

To investigate the role of FSH in ovarian cancer development, the present study examined the expression of FSH receptor (FSH-R) and the effect of FSH on proliferation of normal, preneoplastic, and neoplastic ovarian surface epithelium (OSE) cells. Recently, immortalized OSE (IOSE) cell lines, including IOSE-29 (preneoplastic) and IOSE-29EC (neoplastic), were used. Our results indicated that FSH-R mRNA was expressed and that FSH exerted a growth stimulatory effect in normal, preneoplastic, and neoplastic OSE cells. To investigate the mechanism of the growth stimulatory effect, the activation of MAPKs by FSH was examined in preneoplastic and neoplastic OSE cells. Treatment with FSH resulted in MAPK activation of IOSE-29 and IOSE-29EC cells, whereas the stimulatory effect of FSH on cellular proliferation and MAPK activation was completely abolished in the presence of PD98059, a MAPK kinase inhibitor, suggesting that the growth stimulatory effect of FSH is mediated through MAPK activation in these OSE cells. In a time-dependent study, FSH significantly increased MAPK activity at 5-10 min in IOSE-29 cells. The activated MAPK declined to the control level after 20 min in these cells. Similarly, treatment with FSH significantly induced MAPK activation after 5 min and sustained it for 60 min in IOSE-29EC cells. In addition, treatment with FSH resulted in substantial phosphorylation of Elk-1, confirming that FSH action is mediated via activation of MAPK. In conclusion, we have demonstrated that FSH-R was expressed, and FSH induced growth stimulation in normal, preneoplastic, and neoplastic OSE cells. Furthermore, treatment with FSH stimulated activation of the MAPK cascade and phosphorylated Elk-1 in neoplastic OSE cells. These results suggest that the MAPK cascade may be involved in cellular functions such as growth stimulation in response to FSH in preneoplastic and neoplastic OSE cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994371     DOI: 10.1210/jcem.87.5.8506

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Trans-activation, cis-activation and signal selection of gonadotropin receptors.

Authors:  MyoungKun Jeoung; ChangWoo Lee; Inhae Ji; Tae H Ji
Journal:  Mol Cell Endocrinol       Date:  2006-10-19       Impact factor: 4.102

2.  The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca(2+) mobilization.

Authors:  Richard M Thomas; Cheryl A Nechamen; Joseph E Mazurkiewicz; Alfredo Ulloa-Aguirre; James A Dias
Journal:  Endocrinology       Date:  2011-02-01       Impact factor: 4.736

3.  The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer.

Authors:  Shelby M King; Tyvette S Hilliard; Lucia Y Wu; Randal C Jaffe; Asgerally T Fazleabas; Joanna E Burdette
Journal:  Endocr Relat Cancer       Date:  2011-09-20       Impact factor: 5.678

Review 4.  Microenvironment and pathogenesis of epithelial ovarian cancer.

Authors:  Antonio F Saad; Wei Hu; Anil K Sood
Journal:  Horm Cancer       Date:  2010-12       Impact factor: 3.869

5.  FSH stimulates ovarian cancer cell growth by action on growth factor variant receptor.

Authors:  Y Li; S Ganta; C Cheng; R Craig; R R Ganta; L C Freeman
Journal:  Mol Cell Endocrinol       Date:  2007-01-16       Impact factor: 4.102

Review 6.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

Review 7.  New Predictive Biomarkers for Ovarian Cancer.

Authors:  Ghofraan Abdulsalam Atallah; Nor Haslinda Abd Aziz; Chew Kah Teik; Mohamad Nasir Shafiee; Nirmala Chandralega Kampan
Journal:  Diagnostics (Basel)       Date:  2021-03-07

Review 8.  Targeting signaling pathways in epithelial ovarian cancer.

Authors:  Elisabeth Smolle; Valentin Taucher; Martin Pichler; Edgar Petru; Sigurd Lax; Johannes Haybaeck
Journal:  Int J Mol Sci       Date:  2013-05-02       Impact factor: 5.923

9.  Gonadotropin treatment augments postnatal oogenesis and primordial follicle assembly in adult mouse ovaries?

Authors:  Deepa Bhartiya; Kalpana Sriraman; Pranesh Gunjal; Harshada Modak
Journal:  J Ovarian Res       Date:  2012-11-07       Impact factor: 4.234

10.  Progression of choroidal metastasis of ovarian serous cystoadenocarcinoma after intravitreal bevacizumab treatment.

Authors:  Irene C Kuo; Ruben H Sambuelli; Javier Bono; Ricardo J Smith; Victor E Reviglio
Journal:  Rare Tumors       Date:  2013-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.